Moleculin Biotech CS (MBRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Operating Expenses | 6,644 | 7,135 | 6,185 | 6,677 | 8,919 |
| Operating Income | -6,644 | -7,135 | -6,185 | -6,677 | -8,919 |
| Other Income | -3,091 | 111 | 1,866 | 1,707 | -1,350 |
| Pre-tax Income | -9,735 | -7,024 | -4,319 | -4,970 | -10,269 |
| Net Income Continuous | -9,735 | -7,024 | -4,319 | -4,970 | -10,269 |
| Net Income | $-9,735 | $-7,024 | $-4,319 | $-4,970 | $-10,269 |
| EPS Basic Total Ops | -48.89 | -47.25 | -42.50 | -50.50 | -127.50 |
| EPS Basic Continuous Ops | -49.02 | -47.28 | -42.46 | -50.38 | -127.42 |
| EPS Diluted Total Ops | -48.89 | -47.25 | -42.50 | -50.50 | -127.50 |
| EPS Diluted Continuous Ops | -49.02 | -47.28 | -42.46 | -50.38 | -127.42 |
| EPS Diluted Before Non-Recurring Items | N/A | -52.25 | -55.75 | -50.50 | N/A |
| EBITDA(a) | $-6,613 | $-7,103 | $-6,154 | $-6,645 | $-8,884 |